Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Japanese Catheter Ablation Registry (J-AB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03729232
Recruitment Status : Recruiting
First Posted : November 2, 2018
Last Update Posted : April 14, 2020
Sponsor:
Information provided by (Responsible Party):
Kengo Kusano, National Cerebral and Cardiovascular Center

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.

Condition or disease
Catheter Ablation Cardiac Arrhythmias

Detailed Description:

Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and Cardiovascular Center.

This study is a voluntary nationwide registry and data are collected prospectively using a Research Electronic Data Capture (REDCap) system. Detailed data collection including antiarrhythmic medication is also performed at every September. The acute success rate at discharge and the complications associated with ablation procedure will be collected in all cases. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria. Based on the provided information, the annual incidence and predictive factors for outcome will be investigated by the event assessment committee.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 400000 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Japanese Catheter Ablation Registry
Actual Study Start Date : July 1, 2017
Estimated Primary Completion Date : March 31, 2030
Estimated Study Completion Date : March 31, 2030

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Arrhythmia

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of patients with recurrence of targeted arrhythmia [ Time Frame: Through discharge from hospital, approximately up to 1 weeks ]

Secondary Outcome Measures :
  1. Number of deaths [ Time Frame: Through discharge from hospital, approximately up to 1 weeks ]
    All-cause death, cardiovascular death, and procedure-related death

  2. Number of patients with treatment-related complications [ Time Frame: 3 months ]
    Bleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Inpatients
Criteria

Inclusion Criteria:

  • Patients treated with catheter ablation in Japan

Exclusion Criteria:

  • Patients who refused to consent
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03729232


Contacts
Layout table for location contacts
Contact: Kengo Kusano, MD, PhD +81-6-6170-1070 kusanokengo@ncvc.go.jp
Contact: Misa Takegami, PhD, MPH +81-6-6170-1070 takegami@ncvc.go.jp

Locations
Layout table for location information
Japan
National Cerebral and Cardiovascular Center Recruiting
Suita, Osaka, Japan, 564-8565
Contact: Kengo Kusano, MD, PhD    +81-6-6170-1070    kusanokengo@ncvc.go.jp   
Contact: Misa Takegami, PhD, MPH    +81-6-6170-1070    takegami@ncvc.go.jp   
Sponsors and Collaborators
National Cerebral and Cardiovascular Center
Investigators
Layout table for investigator information
Principal Investigator: Teiichi Yamane, MD, PhD The Jikei University School of Medicine
Principal Investigator: Kengo Kusano, MD, PhD National Cerebral and Cardiovascular Center
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Kengo Kusano, Director of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, National Cerebral and Cardiovascular Center
ClinicalTrials.gov Identifier: NCT03729232    
Other Study ID Numbers: M28-114
UMIN000028288 ( Other Identifier: UMIN-CTR )
First Posted: November 2, 2018    Key Record Dates
Last Update Posted: April 14, 2020
Last Verified: April 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Kengo Kusano, National Cerebral and Cardiovascular Center:
Catheter Ablation
Cardiac Arrhythmias
Registry
Complication
REDCap
Additional relevant MeSH terms:
Layout table for MeSH terms
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes